Current approaches to vision restoration using optogenetic therapy.

Area of Science:

• Neuroscience
• Ophthalmology
• Biotechnology

Background:

• Inherited retinal degenerations like retinitis pigmentosa (RP) cause progressive photoreceptor loss and blindness.
• Inner retinal neurons remain functional in later disease stages, offering therapeutic targets.
• Optogenetic therapy aims to restore vision by introducing light sensitivity to surviving retinal cells.

Purpose of the Study:

• To review visuocortical and behavioral responses following optogenetic therapy in degenerated retinas.
• To evaluate the extent of functional vision restoration achievable for clinical progress.

Main Methods:

• Review of studies employing various opsins (microbial, mammalian, chimeric, ligand-gated, switchable) for optogenetic vision restoration.
• Analysis of reported retinal, visuocortical, and behavioral outcomes.

Main Results:

• Diverse opsins have been explored, differing in spectral sensitivity, kinetics, and amplification.
• While retinal responses are often high-fidelity, functional vision in the visual cortex is less frequently achieved.
• This review specifically examines visual cortex and behavioral data.

Conclusions:

• Optogenetic therapy holds promise for vision restoration in retinal degeneration.
• Further research is needed to optimize therapies for meaningful functional vision, particularly at the cortical level.
• Assessing visuocortical and behavioral outcomes is crucial for therapeutic efficacy.